NEW YORK (360Dx) – Uppsala, Sweden-based Cavidi said today that it has closed $11.5 million in equity financing with Impilo, an investment firm that focuses on Nordic healthcare companies.

Cavidi said it is close to completing development of Ziva, a fully automated reverse-transcriptase viral load platform that aims to meet a need for cost-effective monitoring in countries with a high disease burden. The firm is developing Ziva as a medium-throughput system to meet the requirements of decentralized labs, such as those in district hospitals.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.